Applied Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses

Los Angeles, California, UNITED STATES

LOS ANGELES, Aug. 21, 2020 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email:, to discuss their legal rights, or click here to join the case via The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

On May 13, 2019, Applied Therapeutics conducted its initial public offering (“IPO”), issuing 4 million shares of common stock with a price of $10.00 per share.  On August 17, 2020, Applied Therapeutics disclosed that a partial clinical hold on the Company’s ACTION-Kids study evaluating the Company’s AT-007 product for the treatment of galactosemia was placed by the U.S. Food and Drug Administration (“FDA”).  The FDA cited the need for additional technical information related to ensuring that all of the study’s participants have access to the drug’s benefits.  Applied Therapeutics’ stock price fell $3.53 per share, or 12.07%, on this news, closing at $25.71 per share on August 17, 2020.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar

Attorney Advertising